Agonists for the chemokine receptor CXCR4

ACS Medicinal Chemistry Letters

Volumn 2, Issue 8, 2011, Pages 597-602

  Lefrançois, Marilou ^a   Lefebvre, Marie Reine ^a   Saint Onge, Geneviève ^b   Boulais, Philip E ^a   Lamothe, Simon ^b,c   Leduc, Richard ^a   Lavigne, Pierre ^a   Heveker, Nikolaus ^b,c   Escher, Emanuel ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

agonist; chemotaxis; CXCL12; CXCR4; T140

Indexed keywords

CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 AGONIST; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CHIMERA; DRUG ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; PHOTOAFFINITY LABELING; PRIORITY JOURNAL;

EID: 80051758831     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml200084n     Document Type: Article

References (25)

1. Wu, B.; Chien, E. Y.; Mol, C. D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F. C.; Hamel, D. J.; Kuhn, P.; Handel, T. M.; Cherezov, V.; Stevens, R. C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 2010, 330 (6007) 1066-1071
2. Donzella, G. A.; Schols, D.; Lin, S. W.; Este, J. A.; Nagashima, K. A.; Maddon, P. J.; Allaway, G. P.; Sakmar, T. P.; Henson, G.; De Clercq, E.; Moore, J. P. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor Nat. Med. 1998, 4 (1) 72-77 (Pubitemid 28133082)
3. Schols, D.; Este, J. A.; Henson, G.; De Clercq, E. Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4 Antiviral Res. 1997, 35 (3) 147-156 (Pubitemid 27351415)
4. Zhou, N.; Fang, J.; Acheampong, E.; Mukhtar, M.; Pomerantz, R. J. Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1 Virology 2003, 312 (1) 196-203 (Pubitemid 36918471)
5. DeMarco, S. J.; Henze, H.; Lederer, A.; Moehle, K.; Mukherjee, R.; Romagnoli, B.; Robinson, J. A.; Brianza, F.; Gombert, F. O.; Lociuro, S.; Ludin, C.; Vrijbloed, J. W.; Zumbrunn, J.; Obrecht, J. P.; Obrecht, D.; Brondani, V.; Hamy, F.; Klimkait, T. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles Bioorg. Med. Chem. 2006, 14 (24) 8396-8404 (Pubitemid 44667545)
6. Ichiyama, K.; Yokoyama-Kumakura, S.; Tanaka, Y.; Tanaka, R.; Hirose, K.; Bannai, K.; Edamatsu, T.; Yanaka, M.; Niitani, Y.; Miyano-Kurosaki, N.; Takaku, H.; Koyanagi, Y.; Yamamoto, N. A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (7) 4185-4190 (Pubitemid 36418178)
7. Yang, O. O.; Swanberg, S. L.; Lu, Z.; Dziejman, M.; McCoy, J.; Luster, A. D.; Walker, B. D.; Herrmann, S. H. Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4 J. Virol. 1999, 73 (6) 4582-4589 (Pubitemid 29246716)
8. Tamamura, H.; Hori, A.; Kanzaki, N.; Hiramatsu, K.; Mizumoto, M.; Nakashima, H.; Yamamoto, N.; Otaka, A.; Fujii, N. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer FEBS Lett. 2003, 550 (1-3) 79-83 (Pubitemid 37281361)
9. Tamamura, H.; Omagari, A.; Hiramatsu, K.; Gotoh, K.; Kanamoto, T.; Xu, Y.; Kodama, E.; Matsuoka, M.; Hattori, T.; Yamamoto, N.; Nakashima, H.; Otaka, A.; Fujii, N. Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140 Bioorg. Med. Chem. Lett. 2001, 11 (14) 1897-1902 (Pubitemid 32675313)
10. Tamamura, H.; Xu, Y.; Hattori, T.; Zhang, X.; Arakaki, R.; Kanbara, K.; Omagari, A.; Otaka, A.; Ibuka, T.; Yamamoto, N.; Nakashima, H.; Fujii, N. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: A strong anti-HIV peptide T140 Biochem. Biophys. Res. Commun. 1998, 253 (3) 877-882 (Pubitemid 29039238)
11. Heveker, N.; Montes, M.; Germeroth, L.; Amara, A.; Trautmann, A.; Alizon, M.; Schneider-Mergener, J. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides Curr. Biol. 1998, 8 (7) 369-376 (Pubitemid 28173995)
12. Pelus, L. M.; Bian, H.; Fukuda, S.; Wong, D.; Merzouk, A.; Salari, H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor Exp. Hematol. 2005, 33 (3) 295-307 (Pubitemid 40261311)
13. Li, K.; Chuen, C. K.; Lee, S. M.; Law, P.; Fok, T. F.; Ng, P. C.; Li, C. K.; Wong, D.; Merzouk, A.; Salari, H.; Gu, G. J.; Yuen, P. M. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice Stem Cells. 2006, 24 (1) 55-64
14. Peled, A.; Petit, I.; Kollet, O.; Magid, M.; Ponomaryov, T.; Byk, T.; Nagler, A.; Ben-Hur, H.; Many, A.; Shultz, L.; Lider, O.; Alon, R.; Zipori, D.; Lapidot, T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 Science 1999, 283 (5403) 845-848
15. Muller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M. E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S. N.; Barrera, J. L.; Mohar, A.; Verastegui, E.; Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis Nature 2001, 410 (6824) 50-56 (Pubitemid 32225831)
16. Teicher, B. A.; Fricker, S. P. CXCL12 (SDF-1)/CXCR4 pathway in cancer Clin. Cancer Res. 2010, 16 (11) 2927-2931
17. Hendrix, C. W.; Collier, A. C.; Lederman, M. M.; Schols, D.; Pollard, R. B.; Brown, S.; Jackson, J. B.; Coombs, R. W.; Glesby, M. J.; Flexner, C. W.; Bridger, G. J.; Badel, K.; MacFarland, R. T.; Henson, G. W.; Calandra, G. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection J. Acquired Immune Defic. Syndr. 2004, 37 (2) 1253-1262 (Pubitemid 39281506)
18. De Clercq, E. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil) and potential of other CXCR4 antagonists as stem cell mobilizers Pharmacol. Ther. 2010, 128 (3) 509-518
19. Burger, J. A.; Peled, A. CXCR4 antagonists: Targeting the microenvironment in leukemia and other cancers Leukemia 2009, 23 (1) 43-52
20. Tchernychev, B.; Ren, Y.; Sachdev, P.; Janz, J. M.; Haggis, L.; O'Shea, A.; McBride, E.; Looby, R.; Deng, Q.; McMurry, T.; Kazmi, M. A.; Sakmar, T. P.; Hunt, S., 3rd; Carlson, K. E. Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (51) 22255-22259
21. Wendt, M. K.; Cooper, A. N.; Dwinell, M. B. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells Oncogene 2008, 27 (10) 1461-1471 (Pubitemid 351317456)
22. Wendt, M. K.; Drury, L. J.; Vongsa, R. A.; Dwinell, M. B. Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells Gastroenterology 2008, 135 (2) 508-517
23. Boulais, P. E.; Dulude, D.; Cabana, J.; Heveker, N.; Escher, E.; Lavigne, P.; Leduc, R. Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site Biochem. Pharmacol. 2009, 78 (11) 1382-1390
24. Gupta, S. K.; Pillarisetti, K.; Thomas, R. A.; Aiyar, N. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: Implications for development of selective CXCR4 antagonists Immunol. Lett. 2001, 78 (1) 29-34 (Pubitemid 32709903)
25. Crump, M. P.; Gong, J. H.; Loetscher, P.; Rajarathnam, K.; Amara, A.; Arenzana-Seisdedos, F.; Virelizier, J. L.; Baggiolini, M.; Sykes, B. D.; Clark-Lewis, I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J. 1997, 16 (23) 6996-7007 (Pubitemid 27520800)